STUDY OF PROGNOSIS OF SNAKE BITE IN A TERTIARY CARE CENTRE
Journal of Evidence Based Medicine and Healthcare
BACKGROUND Snake bite is stated to be a neglected public health issue in many tropical and subtropical countries. According to national statistics in India, 5% of all injury deaths and 0.5% of all deaths are reported to be due to snakebites which were more than 30-fold higher than the number declared from hospital records. Variations in the species existence with respect to various regions, under-reporting, traditional, herbal or ayurvedic treatments being the main domain, pose a challenge in
... se a challenge in mitigating the burden of snakebite. This treatment seeking behaviour might lead to development of complications of delayed envenomation. Hence the present study is aimed to observe the outcome of people who seek early treatment and compare it with those who seek delayed treatment in a tertiary care hospital. MATERIALS AND METHODS The present study was conducted in the inpatient wards After taking Ethics committee clearance, 45 patients who were admitted with history of snake bite and who had given informed consent, were included in the study. RESULTS Significant number of subjects who had delayed treatment had increased bleeding time (50.0% v/s. 19.4%), significantly prolonged prothrombin time (19.85 secs v/s. 17.31secs) indicating the status of coagulation abnormalities among those with delayed treatment. They also had significantly higher blood urea levels (90.15 mg/dl v/s. 30.88 mg/dl), serum creatinine (3.12 mg/dl v/s. 1.07 mg/dl) and potassium levels (4.65 mmol/L v/s. 4.09 mmol/L) indicating the worsened kidney functions. CONCLUSION A highly effective treatment exists for snake bite in contrast to many other serious health conditions. Most deaths and serious consequences due to snake bites are entirely preventable by making safe and effective antivenoms more widely available and accessible. The only effective treatments to prevent or reverse most of the venomous effects of snake bites are to provide high quality snake antivenoms and are included in the WHO List of essential medicines. Snake antivenoms are mandated to be part of any primary health care package where snake bites occur.